[JAMA] US Food and Drug Administration Approval of Aducanumab—Is Amyloid Load a Valid Surrogate End Point for Alzheimer Disease Clinical Trials? |
Reward10points
Best Answer
2024-4-18
|
| |
10
Male Carrier of X-Linked Adrenal Leukodystrophy Due to 47, XXY Karyotype
10
A 24-Year-Old Man With Spastic Ataxia and Hypodontia
10
Effects of Tirofiban on Neurological Deterioration in Patients With Acute Ischemic Stroke
10
The Most Difficult Question in a Cognitive Disorders Clinic
10
Acute Corneal Edema in a Middle-Aged Patient
